Pharma
-
Mallinckrodt spinoff to include 7 manufacturing sites in U.S. and Japan
[ad_1] With its plan for a spinoff into two companies, Mallinckrodt will create an API and generics operation with a…
Read More » -
Amgen pays $50M for Molecular Partners’ preclinical Anti-cancer
Amgen is paying Molecular Partners $50 million (€44 million) upfront for world rights to preclinical anti-cancer immune cell activator MP0310.…
Read More » -
Orchard Therapeutics commits to gene therapies production facility with plans to hire 100 workers
[ad_1] Orchard Therapeutics mentioned it supposed to use a few of the proceeds of an IPO to construct a producing…
Read More » -
GlaxoSmithKline’s Shingrix shortage expected to persist ‘throughout 2019’
[ad_1] In the face of “unprecedented” demand for its shingles vaccine, GlaxoSmithKline is doing every little thing it may to…
Read More » -
Generics ‘cartel’ probe expands to a whopping 300 drugs: report
[ad_1] A probe into generic drug value fixing has grown to embrace 300 medication, in accordance to The Washington Post.…
Read More » -
Akorn’s CEO bows out after failing last-ditch bid to save Fresenius merger
[ad_1] Akorn as soon as once more tried and failed to salvage its $4.3 billion merger with Fresenius. Delaware’s high…
Read More » -
1globe Capital Llc. Picked Up Exelixis Inc. (NASDAQ:EXEL) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Exelixis Inc. (NASDAQ:EXEL) reported that…
Read More » -
Citius Pharmaceuticals (NASDAQ: CTXR) Successfully Raises $10 Million
Citius Pharmaceuticals Successfully Raises $10 Million – CTXR announced today that the Company completed the largest capital raise in its…
Read More » -
Disclosure, finances, and the oncologist
[ad_1] Conflict-of-interest guidelines missing enforcement According to the BMJ, oncologists in the US have an issue with disclosure. Research in…
Read More » -
Cutting-edge biotech spurring growth in infectious disease testing
[ad_1] Increase in adoption of superior applied sciences equivalent to molecular & fast techniques, rise in incidence of infectious illnesses,…
Read More »